Tech Company Financing Transactions
Alithea Genomics Funding Round
Novalis Biotech, TechU Ventures Fund and private investors participated in a $3.2 million Seed venture round for Alithea Genomics. The round was announced by the company on 3/14/2024.
Transaction Overview
Company Name
Announced On
3/14/2024
Transaction Type
Venture Equity
Amount
$3,165,000
Round
Seed
Investors
Novalis Biotech (Lead Investor)
Proceeds Purpose
The company intends to use the funds to continue commercialization and expand manufacturing capacity of its RNA sequencing products, advance the development of new technologies, and establish a subsidiary in the United States.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Route de la Corniche 5
Epalinges, 1066
Switzerland
Epalinges, 1066
Switzerland
Phone
Website
Email Address
Overview
At Alithea Genomics we are committed to developing solutions that simplify and streamline the generation of "big RNA data", which we believe will constitute the foundation of tomorrow's research and medicine. Our technologies enable our clients to discover new biomarkers and develop new drugs at a fraction of the costs and time as compared to what was possible before.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Riccardo Dainese
Chief Technical Officer
Daniel Alpern
Browse more venture capital transactions:
Prev: 3/14/2024: Mindfuel venture capital transaction
Next: 3/14/2024: Lily AI venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs